Zachary Silbersher v. Allergan, Inc.
46 F.4th 991
United States Court of Appeals for the Ninth CircuitAugust 25, 202221-15420California4,564 words
Opinion
Opinion
Gould, J.
FOR PUBLICATION
UNITED STATES COURT OF APPEALS
FOR THE NINTH CIRCUIT
UNITED STATES OF AMERICA; STATE No. 21-15420
OF CALIFORNIA; STATE OF
COLORADO; STATE OF D.C. No. CONNECTICUT; STATE OF 3:18-cv-03018-
DELAWARE; STATE OF FLORIDA; JCS
STATE OF GEORGIA; STATE OF
HAWAII; STATE OF ILLINOIS; STATE
OF INDIANA; STATE OF IOWA; STATE OPINION
OF LOUISIANA; STATE OF
MARYLAND; STATE OF MICHIGAN;
STATE OF MINNESOTA; STATE OF
MONTANA; STATE OF NEVADA;
STATE OF NEW JERSEY; STATE OF
NEW MEXICO; STATE OF NEW YORK;
STATE OF NORTH CAROLINA; STATE
OF OKLAHOMA; STATE OF RHODE
ISLAND; STATE OF TENNESSEE;
STATE OF TEXAS; STATE OF
VERMONT; STATE OF WASHINGTON;
COMMONWEALTH OF
MASSACHUSETTS; COMMONWEALTH
OF VIRGINIA; DISTRICT OF
COLUMBIA, ex rel ZACHARY SILBERSHER, Relator, Plaintiffs-Appellees,
v. ALLERGAN, INC.; ALLERGAN USA,
INC.; ALLERGAN SALES, LLC;
FOREST LABORATORIES HOLDINGS,
LTD.; ADAMAS PHARMA LLC;
ADAMAS PHARMACEUTICALS, INC.,
Defendants-Appellants.
Appeal from the United States District Court for the Northern District of California Joseph C. Spero, Magistrate Judge, Presiding